Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Zhejiang Provincial People's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Baylor College of Medicine
City of Hope Medical Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Lyell Immunopharma, Inc.
Therapeutic Advances in Childhood Leukemia Consortium
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AIDS Malignancy Consortium
Kura Oncology, Inc.
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
St. Jude Children's Research Hospital
Janssen Research & Development, LLC
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
St. Jude Children's Research Hospital
Canadian Cancer Trials Group
Beijing Biotech
Tongji Hospital
Gilead Sciences
National Institutes of Health Clinical Center (CC)
The General Hospital of Western Theater Command
Stanford University
Memorial Sloan Kettering Cancer Center
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
Affiliated Hospital to Academy of Military Medical Sciences
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
Masonic Cancer Center, University of Minnesota